Sanctura Indevus Pharmaceuticals, Inc. - Treatment for Overactive Bladder
Sanctura belongs to a class of anticholinergic compounds known as muscarinic receptor antagonists which relax smooth muscle tissue found in the bladder. Sanctura is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and urinary frequency.Posted: May 2004
Related articles
- Indevus Announces FDA Approval of Sanctura XR - August 6, 2007
Sanctura (trospium chloride) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
